Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus

作者：Hu Bing^*; Jiang Jiawei; Zhan Jianbo; Li Guoming; Jiang Yongzhong; Guan Xuhua; Chen Yuanding; Fang Zhizheng

来源：Virology Journal, 2014, 11(1): 142.

DOI：10.1186/1743-422X-11-142

• Respiratory syncytial virus (RSV) Long strain
• Reverse genetics
• Attenuated vaccine candidates
• Immunogenicity
• Protection

Background: Respiratory Syncytial Virus (RSV) is an important human respiratory pathogen, particularly of infants and older adults, and despite several decades of research and development, no licensed vaccine is available. Studies have confirmed that enhancement of RSV disease does not occur after inoculation with RSV live-attenuated vaccine candidates, making such vaccines preferable. In this paper, reverse genetics was used to construct two recombinant viruses, a recombinant Long strain (rLong) and rLong-Delta G-EGFP; rLong-Delta G-EGFP is a recombinant mutant in which G was replaced with the EGFP gene, based on the Long strain of RSV.
Results: Both rLong and rLong-Delta G-EGFP were constructed successfully and recovered in Hep-2 cells, and autofluorescence was observed in rLong-Delta G-EGFP-infected cells during consecutive passages. Titers of rLong and rLong-Delta G-EGFP were similar to 100-fold lower than the parental strain. Although virulence was attenuated, high titers of neutralizing antibodies were induced in BALB/c mice after being inoculated with recombinant viruses in a three-dose schedule. Unexpectedly, the neutralizing antibody titer in rLong-Delta G-EGFP-immunized recipients did not decline significantly compared with the rLong strain. Protective efficacy of recombinant viruses in lung tissue was up to 100%, and the serum neutralizing antibody levels could stabilize at 21 days with no significant fall post-challenge. Enzyme-linked immunospot (ELISPOT) assays showed that both recombinant viruses were capable of inducing CD8(+) T cell immune responses, which are crucial for virus clearance, and that rLong stimulated a higher level of IFN gamma production by comparison. In terms of inducing a balanced immune response, rLong-Delta G-EGFP elicited slightly higher levels of IgG2a antibodies and lower levels of IgG1/IgG2a than the rLong virus.
Conclusions: This study suggested that immunization with rLong and rLong-Delta G-EGFP were immunogenic and protected against RSV infection in the lower respiratory tract of BALB/c mice better than in the nose. Because of a relative low IgG1/IgG2a ratio, rLong-Delta G-EGFP was more inclined to make CD4(+) T cells, shifting toward a Th1-type response, indicating that the generation of a more balanced Th1/Th2 response was desirable. This explorative study on the recombinant Long viruses also contributed to obtaining more RSV attenuated candidates by a reverse genetics approach.

• 出版日期2014-8-8
• 单位中国医学科学院医学生物学研究所; 湖北省疾病预防控制中心